Companies › BIAF

BIOAFFINITY TECHNOLOGIES INC (BIAF)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001712762 · EDGAR filings · Updated 2026-07-27

BIOAFFINITY TECHNOLOGIES INC (BIAF) has reported institutional ownership of 5.4%, with 14 institutional managers holding positions valued at $928.5K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (2)

• 2026-07-27 — Current report (8-K) filed
• 2026-07-22 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-07 — Current report (8-K) filed
• 2026-06-30 — Current report (8-K) filed
• 2026-06-18 — Current report (8-K) filed
• 2026-06-18 — Prospectus supplement (424B4) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, BIOAFFINITY TECHNOLOGIES INC has 14 institutional holders and institutional ownership of 5.4%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 1 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

JYONG BIOTECH LTD (MENS) · Beyond Air Inc (XAIR) · SEASTAR MEDICAL HOLDING CORP (ICU) · Citius Pharmaceuticals Inc (CTXR) · BULLFROG AI HLDGS INC (BFRG) · Tempest Therapeutics Inc (TPST)